Literature DB >> 2420712

Oral tolerance to ovalbumin in mice: studies of chemically modified and 'biologically filtered' antigen.

M G Bruce, A Ferguson.   

Abstract

Suppression of systemic immunity after the feeding of antigen was investigated in mice by means of serum transfer experiments. Serum collected from mice 1 hr after a single intragastric dose of 25 mg OVA induced suppression of systemic DTH when injected intraperitoneally into recipient mice. This suppression was found to be restricted to the cell-mediated limb of immunity and was antigen-specific. A postulated function of the intestine, conversion of antigen into tolerogenic form by means of intestinal antigen processing, was studied by attempting to mimic intestinal alteration of OVA by chemical modification of the antigen. Parenteral injection of mice with either deaggregated or denatured OVA did not produce the typical pattern of unresponsiveness seen in animals given intestinally processed OVA. Intestinal processing was also shown to be distinct from systemic antigen processing. Mice injected with serum containing systemically 'filtered' OVA did not become tolerant to OVA in the manner of recipients of serum from OVA-fed mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420712      PMCID: PMC1453856     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  PHAGOCYTOSIS OF THE ANTIGEN, A CRUCIAL STEP IN THE INDUCTION OF THE PRIMARY RESPONSE.

Authors:  P C FREI; B BENACERRAF; G J THORBECKE
Journal:  Proc Natl Acad Sci U S A       Date:  1965-01       Impact factor: 11.205

2.  Studies on the induction of immunologic unresponsiveness. 3. Antigen form and mouse strain variation.

Authors:  E S Golub; W O Weigle
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

3.  Antigen recognition by T cells and B cells: recognition of cross-reactivity between native and denatured forms of globular antigens.

Authors:  R W Chesnut; R O Endres; H M Grey
Journal:  Clin Immunol Immunopathol       Date:  1980-03

4.  Strain differences in ease of tolerance induction to bovine gamma-globulin: dependence on macrophage function.

Authors:  M L Lukić; C Cowing; S Leskowitz
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

5.  Protein uptake by the intestine: evidence for absorption of intact macromolecules.

Authors:  A L Warshaw; W A Walker; K J Isselbacher
Journal:  Gastroenterology       Date:  1974-05       Impact factor: 22.682

6.  Reaginic antibody formation in the mouse. VI. Suppression of IgE and IgG antibody responses to ovalbumin following the administration of high dose urea-denatured antigen.

Authors:  K Takatsu; K Ishizaka
Journal:  Cell Immunol       Date:  1975-12       Impact factor: 4.868

7.  Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide.

Authors:  A M Mowat; S Strobel; H E Drummond; A Ferguson
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

8.  Hypersensitivity in the small intestinal mucosa. V. Induction of cell-mediated immunity to a dietary antigen.

Authors:  A M Mowat; A Ferguson
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

9.  Immunological tolerance of the mouse IgE system: dissociation between T cell tolerance and suppressor cell activity.

Authors:  W D Colby; G H Strejan
Journal:  Eur J Immunol       Date:  1980-08       Impact factor: 5.532

10.  Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen.

Authors:  S Strobel; A M Mowat; H E Drummond; M G Pickering; A Ferguson
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

  10 in total
  23 in total

1.  Oral tolerance, an active immunologic process mediated by multiple mechanisms.

Authors:  H L Weiner
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Authors:  Maria F Silva; Alice O Kamphorst; Elize A Hayashi; Maria Bellio; Claudia R Carvalho; Ana M C Faria; Kátia C C Sabino; Marsen G P Coelho; Alberto Nobrega; Daniel Tavares; Antonio C Silva
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

3.  Visualizing the T-cell response elicited by oral administration of soluble protein antigen.

Authors:  E Williamson; J M O'Malley; J L Viney
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

Review 4.  Oral tolerance and the treatment of rheumatoid arthritis.

Authors:  H L Weiner; Y Komagata
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Oral tolerance.

Authors:  W Strober; B Kelsall; T Marth
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

Review 6.  Lymphoepithelial interactions in the mucosal immune system.

Authors:  P Brandtzaeg; L M Sollid; P S Thrane; D Kvale; K Bjerke; H Scott; K Kett; T O Rognum
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

7.  The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen.

Authors:  H J Peng; M W Turner; S Strobel
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

8.  Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system.

Authors:  E Furrie; M W Turner; S Strobel
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

9.  Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma.

Authors:  Nina Almqvist; Anna Lönnqvist; Susanne Hultkrantz; Carola Rask; Esbjörn Telemo
Journal:  Immunology       Date:  2008-03-19       Impact factor: 7.397

10.  Maternal dietary antigens and the immune response in the offspring of the guinea-pig.

Authors:  E Telemo; I Jakobsson; B R Weström; H Folkesson
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.